ACARIZAX

This brand name is authorized in the following countries: Austria Canada Finland France Hong Kong Ireland Netherlands New Zealand Poland Romania Turkey

Active ingredients

The drug ACARIZAX contains a combination of these active pharmaceutical ingredients (APIs):

UNII PR9U2YPF3Q - DERMATOPHAGOIDES FARINAE
UNII 57L1Z5378K - DERMATOPHAGOIDES PTERONYSSINUS

Medication package inserts

Below package inserts are available for further reading:

Title
Information Source
Document Type
 
Medicines & Healthcare Products Regulatory Agency (GB)
Summary of Product Characteristics (SPC)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
House dust
V Various → V01 Allergens → V01A Allergens → V01AA Allergen extracts
Discover more medicines within V01AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
CA
Health Products and Food Branch
Identifier(s): 02463644
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 186748, 555047
FR
Base de données publique des médicaments
Identifier(s): 67813445
HK
Department of Health Drug Office
Identifier(s): 65924
NL
Z-Index G-Standaard, PRK
Identifier(s): 205400
NZ
Medicines and Medical Devices Safety Authority
Identifier(s): 18800
PL
Rejestru Produktów Leczniczych
Identifier(s): 100330160
RO
Agenția Națională a Medicamentului și a Dispozitivelor Medicale
Identifier(s): W67212001, W67212002, W67212003
TR
İlaç ve Tıbbi Cihaz Kurumu
Identifier(s): 8681078093945, 8681078093952, 8681078093969

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.